Loading... 2 0 5 0 false
Credit Name
Jennifer K Mooi
Full Name
Mooi, Jennifer K
 
 
Loading... 3 0 5 0 false

Publications

Results 1-3 of 3 (Search time: 0.003 seconds).

Publication YearTitleAuthor(s)
129-Jan-2021Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study.Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C 
21-Nov-2018The prognostic impact of Consensus Molecular Subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.Mooi, Jennifer K ; Wirapati, P; Asher, R; Lee, C K; Savas, P S; Price, T J; Townsend, A; Hardingham, J; Buchanan, D; Williams, D ; Tejpar, S; Mariadason, John M ; Tebbutt, Niall C 
32018Cell Line Models of Molecular Subtypes of Colorectal Cancer.Mooi, Jennifer K ; Luk, Ian Y; Mariadason, John M